Paper Details

  1. Home
  2. Paper Details

Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?

Author: SimoonsM L, van HoutB A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

The cost-effectiveness of statin treatment for the prevention of coronary heart disease was analyzed in The Netherlands.
Paper Details　
Original Abstract of the Article :
Treatment guidelines have been developed for both "primary" and "secondary" prevention of coronary heart disease. These should consider both the efficacy as well as the costs of such treatment, particularly the costs of treatment with HMG co-enzyme A reductase inhibitors (statins). In the context of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/11350107

データ提供：米国国立医学図書館（NLM）

Balancing the Scales: Cost-Effectiveness of Statins for Heart Health

The field of cardiology constantly navigates the desert of cost-effectiveness, seeking to optimize treatment strategies while ensuring affordability. This research, like a wise traveler assessing the value of different routes across the desert, examines the cost-effectiveness of statins for preventing coronary heart disease. The study analyzed the costs associated with statin treatment and compared them to the potential benefits of preventing heart disease. This is like weighing the value of a precious oasis against the effort required to reach it – finding the right balance between cost and benefit.

A Strategic Approach to Preventing Heart Disease

The study's findings can help guide decisions about statin use for both primary and secondary prevention of heart disease. It can help healthcare providers make informed decisions, like choosing the most efficient and effective path across a vast desert landscape. This research provides valuable information for creating cost-effective strategies for preventing heart disease.

Health Benefits and Implications

This study reminds us that healthcare decisions are not simply about treating diseases but also about optimizing the use of resources. It emphasizes the importance of balancing cost and effectiveness in preventing heart disease, a condition that can have significant health and economic consequences. Understanding the cost-effectiveness of statins can help individuals and healthcare systems make informed decisions that promote long-term health and well-being.

Dr.Camel's Conclusion

The desert of healthcare is vast and complex, and finding the most effective and affordable routes is an ongoing challenge. This research offers valuable insights into the cost-effectiveness of statins, guiding healthcare providers and policymakers in their quest to optimize heart health strategies. By carefully weighing the costs and benefits, we can ensure that everyone has access to the best possible care.

Date :
  1. Date Completed 2001-09-06
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

11350107

DOI: Digital Object Identifier

S0195668X0092308X

Related Literature

Article Analysis
・Effective treatment of statins
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.